Aktas Z, Aridogan A, Kayacan CB, Aydin D (2007).Resistance to macrolide, lincosamide and streptogramin antibiotics in Staphylococci isolated in Istanbul, Turkey. J. Microbiol. 45:286-290.

Baddour MM, Abuelkheir MM, Fatani AJ (2006). Trends in antibiotic susceptibility patterns and epidemiology of MRSA isolates from several hospitals in Riyadh, Saudi Arabia. Ann. Clin. Microbiol. Antimicrob. 5(1):1.
Crossref

Bannerman TL, Peacock SJ. Staphylococcus, Micrococcus and other catalase-positive cocci. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, editors. Manual of clinical microbiology. 9th ed. Washington [DC]: ASM Press; 2007. Pp. 390-411.

Cetin ES, Gunes H, Kaya S, Aridogan BC, Demirci M (2010). Distribution of genes encoding resistance to macrolides, lincosamides and streptogramins among clinical staphylococcal isolates in a Turkish university hospital. J. Microbiol. Immunol. Infect. 43(6):524-529.
Crossref

Ciraj AM, Vinod P, Sreejith G, Rajani K (2009). Inducible clindamycin resistance among clinical isolates of staphylococci. Indian J. Pathol. Microbiol. 52:49-51.
Crossref

Clinical and Laboratory Standards Institute (CLSI) (2013). Performance Standards For Antimicrobial Susceptibility Testing, Twenty-Third Informational Supplement, M100-S21. Clin. Lab. Stand. Inst. 32:1-184.

Coutinho VD, Paiva RM, Reiter KC, de-Paris F, Barth AL, Machado AB (2010). Distribution of erm genes and low prevalence of inducible resistance to clindamycin among staphylococci isolates. Brazilian Journal of Infectious Diseases 14(6):564-568.
Crossref

da Paz Pereira JN, Rabelo MA, da Costa Lima JL, Neto AM, de Souza Lopes AC, Maciel MA (2016). Phenotypic and molecular characterization of resistance to macrolides, lincosamides and type B streptogramin of clinical isolates of Staphylococcus spp. of a university hospital in Recife, Pernambuco, Brazil. Braz. J. Infect. Dis. 20(3):276-81.
Crossref

Dardi CK, Khare AS (2013).Inducible clindamycin resistance in Staphylococcus aureus in a tertiary care rural hospital. Indian J. Basic Appl. Med. Res. 7(2):686-693.

Gadepalli R, Dhawan B, Mohanty S, Kapil A, Das BK, Chaudhry R (2006). Inducible clindamycin resistance in clinical isolates of Staphylococcus aureus. Indian J. Med. Res.123(4):571-573.

Ghanbari F, Ghajavand H, Havaei R, Jami MS, Khademi F, Heydari L, Shahin M, Havaei SA (2016). Distribution of erm genes among Staphylococcus aureus isolates with inducible resistance to clindamycin in Isfahan, Iran. Adv. Biomed. Res. 5

Gherardi G, De Florio L, Lorino G, Fico L, Dicuonzo G (2009). Macrolide resistance genotypes and phenotypes among erythromycin-resistant clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci, Italy FEMS Immunol. Med.Microbiol. 55(1):62-67.
Crossref

Goudarzi G, Tahmasbi F, Anbari K, Ghafarzadeh M (2016). Distribution of Genes Encoding Resistance to Macrolides Among Staphylococci Isolated From the Nasal Cavity of Hospital Employees in Khorramabad, Iran. Iran. Red Crescent Med. J.18(2).

Gupta V, Datta P, Rani H, Chander J (2009). Inducible clindamycin resistance in Staphylococcus aureus: A study from North India. J. Postgrad. Med. 55(3):176.
Crossref

Mahesh CB, Ramakant BK, Jagadeesh VS (2013).The prevalence of inducible and constitutive clindamycin resistance among the nasal isolates of staphylococci. J. Clin. Diagn. Res. 7:1620-1622.
Crossref

Martineau F, Picard FJ, Lansac N, Ménard C, Roy PH, Ouellette M, Bergeron MG (2000). Correlation between the Resistance Genotype Determined by Multiplex PCR Assays and the Antibiotic Susceptibility Patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents Chemother. 44(2):231-238.
Crossref

Memariani M, Pourmand MR, Shirazi MH, Soltan Dallal MM, Abdolsamadi Z, Mardani N (2009).The importance of inducible clindamycin resistance in enterotoxin positive S. aureus isolated from clinical samples. Tehran Univ. Med. J. 67:250-256.

Nascimento TC, Silva VL, Araújo ML, Campos MB, Ferreira-Machado AB, Ferreira DC, Oliveira MG, Diniz CG (2015). Epidemiology and antimicrobial susceptibility trends of methicillin-resistant Staphylococcus aureus in a tertiary hospital. Int. Arch. Med. 8.
Crossref

Navaneeth BV (2006). A preliminary in vitro study on inducible and constitutive clindamycin resistance in Staphylococcus aureus from a South Indian tertiary care hospital. Int. J. Infect. Dis.10(2):184-185.
Crossref

Otsuka T, Zaraket H, Takano T, Saito K, Dohmae S, Higuchi W, Yamamoto T (2007). Macrolide–lincosamide–streptogramin B resistance phenotypes and genotypes among Staphylococcus aureus clinical isolates in Japan. Clin. Microbiol. Infect. 13(3):325-327.
Crossref

Prabhu K, Rao S, Rao V (2011). Inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples. J. Lab. Phys. 3:25-27.
Crossref

Saderi H, Emadi B, Owlia P (2011). Phenotypic and genotypic study of macrolide, lincosamide and streptogramin B (MLSB) resistance in clinical isolates of Staphylococcus aureus in Tehran, Iran. Med. Sci. Monit. 17:BR48-BR53.
Crossref

Schreckenberger PC, Ilendo E, Ristow KL (2004). Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative Staphylococci in a community and a tertiary care hospital. J. Clin. Microbiol. 42(6):2777-2779.
Crossref

Seifi N, Kahani N, Askari E, Mahdipour S, Naderi-Nasab M (2012). Inducible clindamycin resistance in Staphylococcus aureus isolates recovered from Mashhad, Iran. Iran. J. Microbiol. 4(2):82-86.

Valle DL, Paclibare PA, Cabrera EC, Rivera WL (2016). Molecular and phenotypic characterization of methicillin-resistant Staphylococcus aureus isolates from a tertiary hospital in the Philippines. Trop. Med. Health 44(1):1.
Crossref

Zmantar T, Kouidhi B, Miladi H, Bakhrouf A (2011). Detection of macrolide and disinfectant resistance genes in clinical Staphylococcus aureus and coagulase-negative staphylococci. BMC Res. Notes 4(1):453.
Crossref